Trial Profile
Phase 2 Study of Preoperative Chemotherapy With Abraxane and Gemcitabine Followed by Chemoradiation for Borderline Resectable or Node-Positive Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary) ; Capecitabine; Fluorouracil
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 14 Aug 2023 Status changed from active, no longer recruiting to completed.
- 02 Sep 2021 Planned End Date changed from 12 Nov 2021 to 12 Mar 2022.
- 11 Jan 2021 Planned End Date changed from 12 Nov 2020 to 12 Nov 2021.